MUMBAI: The government has finally got cracking on regulating harmful and irrational combination medicines in the market, directing pharma manufacturers to prove their safety and efficacy claims. This comes close on the heels of a recent move banning three widely used medicines, including diabetes drug pioglitazone. Such combination medicines, also called fixed dose combinations (FDCs), are popular across several therapeutic areas like painkillers, antibiotics, cough remedies and anti-depressants. It is believed that a sizeable number of these...
↧
